Transfusion therapy (Sickle-cell disease) Transfusion therapy (Sickle-cell disease) Red blood cells (erythrocytes) from donors contain normal hemoglobin (HbA), and transfusion of normal red blood cells into people with sickle cell disease reduces the percentage of red cells in the circulation containing the abnormal hemoglobin (HbS). Although transfusion of donor red blood cells can ameliorate and even prevent complications of sickle cell disease in certain circumstances, transfusion therapy is not universally beneficial in sickle cell disease. There are two main types of transfusion, simple red cell transfusion and exchange transfusion. Involves transfusing red blood cells without removing any of the patient’s blood. Exchange transfusion involves
Blood red dark red state, but quickly oxygenates upon exposure to air, turning a brighter shade of red. This happens more quickly with smaller volumes of blood such as a pinprick and less quickly from cuts or punctures that cause greater blood flows such as a puncture in the basilic vein: all blood collected during a phlebotomy procedure is deoxygenated blood, and it does not usually have a chance to become oxygenated upon leaving the body. Arterial blood, which is already oxygenated, is also already a brighter shade of red— this is the blood see from a pulsating neck, arm, or leg